SCHEMBL26209740

C[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)COCCOCCOCCNC(=O)CCCC[C@H]1SC[C@H]2NC(=O)N[C@H]21

nearest known ligand 0.50

Predicted protein targets (top 16)

	gene	UniProt	supporting neighbours	confidence
▸	APLNR	P35414	1/20	0.50

▸	PLG	P00747	2/20	0.50

▸	PRSS1	P07477	2/20	0.50

▸	PRSS2	P07478	2/20	0.50

▸	PRSS3	P35030	2/20	0.50

▸	TPSAB1	Q15661	2/20	0.50

▸	F2	P00734	1/20	0.50

▸	RAMP3	O60896	8/20	0.47

▸	CALCR	P30988	8/20	0.47

▸	CXCR4	P61073	3/20	0.47

▸	KDM1A	O60341	1/20	0.47

▸	MAOB	P27338	1/20	0.47

▸	KDM5A	P29375	1/20	0.47

▸	KDM1B	Q8NB78	1/20	0.47

▸	NMUR2	Q9GZQ4	4/20	0.46

▸	NMUR1	Q9HB89	4/20	0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL26209751	0.94	PLG (0.53)	APLNRPLGPRSS1PRSS2PRSS3
SCHEMBL22423719	0.81	RAMP3 (0.56)	RAMP3CALCRKDM1AMAOBKDM5A
SCHEMBL24601727	0.77	GLP1R (0.60)	CXCR4
SCHEMBL26346380	0.77	GLP1R (0.60)	CXCR4
Biotin SCHEMBL6521802	0.76	GLP1R (0.59)	APLNRRAMP3CALCR
SCHEMBL10358936	0.76	LCK (0.50)	APLNRPLGPRSS1PRSS2PRSS3
SCHEMBL12984646	0.76	RAMP3 (0.63)	APLNRRAMP3CALCR
SCHEMBL12984102	0.75	RAMP3 (0.66)	APLNRRAMP3CALCRCXCR4
SCHEMBL3805702	0.75	RAMP3 (0.55)	F2RAMP3CALCRCXCR4NMUR2
SCHEMBL22550671	0.75	RAMP3 (0.53)	PLGPRSS1PRSS2PRSS3TPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-11719705-B2	IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making	INDI MOLECULAR, INC. (US)	2023-08-08	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-11719705-B2	IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making	IL17A, IL23R, IL15	APLNR 432/4885PLG 1225/4885PRSS1 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.